inhaled

Olodaterol hydrochloride (BI-1744 HCl) 是一种长效的、选择性 β2-adrenoceptor(β2-AR) 激动剂 (EC50=0.1 nM；pKi= 9.14 for human β2-adrenoceptor)，可用于慢性阻塞性肺疾病 (COPD) 和肺纤维化的研究。

Laninamivir octanoate (CS-8958) 是一种长效流感神经氨酸酶抑制剂，是Laninamivir 的前药， 具有优异的抗流感病毒活性。

Ensifentrine (Ensifentrinum) 是首创的吸入式磷酸二酯酶 3 (PDE3) 和PDE4双重抑制剂，IC50分别为 0.4 nM 和 1479 nM。它具有支气管保护和抗炎作用，可用于研究慢性阻塞性肺疾病 (COPD) 。

Olodaterol 是一种长效的、选择性 β2-adrenoceptor(β2-AR) 激动剂 (EC50=0.1 nM；pKi= 9.14 for human β2-adrenoceptor)，可用于慢性阻塞性肺疾病 (COPD) 和肺纤维化的研究。

Budesonide (Pulmicort) 是吸入型糖皮质类固醇，是一种口服具有活性的糖皮质激素受体激动剂。它能够减小肺部肿瘤的体积，逆转 DNA 低度甲基化，调节基因的 mRNA 表达。它是能够用于哮喘的抗炎药。

TD139 是一种吸入式半乳糖凝集素-3 (Gal-3) 的小分子抑制剂，具有潜在的抗纤维化活性，常被用于研究特发性肺纤维化。

Sulukast 是一种有效的吸入白三烯拮抗剂，在豚鼠中被发现可有效预防白三烯和抗原诱导的支气管痉挛。

Potassium iodide 用于治疗过度活跃的甲状腺，并保护甲状腺免受吞咽或吸入放射性碘的辐射影响。可在意外接触放射性碘后或服用含放射性碘的药物前后使用。

AZD5423 是可吸入的非甾体糖皮质激素受体选择性调节剂，能够有效降改善轻度过敏性哮喘患者的过敏原诱导反应。

PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 is an effective inhibitor of inhaled p38 MAPK. PF-03715455 displays some selectivity for p38α over p38β (respective IC50: 0.88 and 23 nM). PF-0371545

TPI-1020是一种新型的抗炎皮质类固醇和一氧化氮(NO)供体，源自布地奈德。TPI-1020表现出浓度依赖的支气管扩张作用，该作用通过释放的NO通过cGMP依赖途径介导。研究表明，TPI-1020将皮质类固醇和释放NO的活性结合起来，在治疗哮喘急性支气管收缩事件中可能具有益处，并可能减少吸入性beta(2)-肾上腺受体激动剂的所需剂量。

Methylhexanamine hydrochloride 是一种脂肪胺和血管收缩剂，通过吸入鼻粘膜，发挥鼻充血减充血剂的作用。

Aztreonam lysine is an inhaled anti-pseudomonal treatment for people who have pulmonary Pseudomonas aeruginosa infection with cystic fibrosis (CF).

Abediterol (LAS100977) is a new potent, long-acting inhaled beta (2) -adrenergic receptor agonist being developed for the treatment of asthma and chronic obstructive pulmonary disease.

AZD-8871 can present a novel treatment approach to chronic obstructive pulmonary disease [COPD] and potentially also asthma (in combination with an inhaled corticosteroid [ICS]).

Zy 15109 can be used as inhaled mast cell stabilizer.

AZD8154 is a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.

Nezulcitinib (TD-0903) 是一种吸入的、肺选择性的 pan-Janus kinase (JAK) 抑制剂，能够用于研究 COVID-19 相关急性肺损伤及氧合受损。

Batefenterol Succinate is a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.

Cromoglicic acid , cromolyn (USAN), cromoglycate (former BAN), or cromoglicate, is traditionally described as a mast cell stabilizer, and is commonly marketed as the sodium salt sodium cromoglicate or cromolyn sodium. This drug prevents the release of inflammatory chemicals such as histamine from mast cells. Because of their convenience (and perceived safety), leukotriene receptor antagonists have largely replaced it as the non-corticosteroid treatment of choice in the treatment of asthma. Cromoglicic acid requires administration four times daily, and does not provide additive benefit in combination with inhaled corticosteroids.

LAS195319 is a potent and selective inhaled PI3Kδ Inhibitor (IC50 = 0.5 nM) for the Treatment of Respiratory Diseases.

Seralutinib (GB002) 是可吸入的PDGFRα 和 PDGFRβ激酶抑制剂，可用于研究肺动脉高压。

GDC-0214 是一种吸入式小分子 JAK1 抑制剂，可降低呼出一氧化氮 (Feno) 的分数。